This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Jeffrey D. Lorenzen net worth and biography

Jeffrey Lorenzen Biography and Net Worth

EVP of American Equity Investment Life

Jeffrey D. Lorenzen, CFA, is Executive Vice President and Chief Risk Officer of American Equity Investment Life Holding Company and American Equity Investment Life Insurance Company.

Prior to joining American Equity as Senior Vice President and Chief Investment Officer in February 2009, he was the President and Chief Investment Officer of WB Capital Management Inc., a wholly-owned subsidiary of West Bancorporation, Inc. He also served on the board of directors for WB Capital Management, Inc., and was a member of the management committee of West Bancorporation (Nasdaq; WTBA). Prior to 2006, Mr. Lorenzen was President and Chief Investment Officer of Investors Management Group, where he spent 14 years in a variety of investment leadership positions. He started his career at Statesman as a high-yield credit analyst in 1989.

Mr. Lorenzen received his B.B.A. in finance from the University of Iowa and and M.B.A. from Drake University. He earned his Chartered Financial Analyst (CFA) designation in 1993. Mr. Lorenzen has more than 25 years of experience in the investment and life insurance industries.

What is Jeffrey D. Lorenzen's net worth?: The estimated net worth of Jeffrey D. Lorenzen is at least $1.74 million as of September 21st, 2023. Mr. Lorenzen owns 30,900 shares of American Equity Investment Life stock worth more than $1,736,889 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Lorenzen may own. Additionally, Mr. Lorenzen receives an annual salary of $1,080,000.00 as EVP at American Equity Investment Life. Learn More about Jeffrey D. Lorenzen's net worth.
How old is Jeffrey D. Lorenzen?: Mr. Lorenzen is currently 58 years old. There are 5 older executives and no younger executives at American Equity Investment Life. The oldest executive at American Equity Investment Life is Mr. James Louis Hamalainen, Executive VP & Chief Investment Officer, who is 59 years old. Learn More on Jeffrey D. Lorenzen's age.
What is Jeffrey D. Lorenzen's salary?: As the EVP of American Equity Investment Life Holding, Mr. Lorenzen earns $1,080,000.00 per year. There are 3 executives that earn more than Mr. Lorenzen. The highest earning executive at American Equity Investment Life is Mr. Anant Bhalla, President, CEO & Director, who commands a salary of $4,780,000.00 per year. Learn More on Jeffrey D. Lorenzen's salary.
How do I contact Jeffrey D. Lorenzen?: The corporate mailing address for Mr. Lorenzen and other American Equity Investment Life executives is 6000 Westown Parkway, West Des Moines IA, 50266. American Equity Investment Life can also be reached via phone at (515) 221-0002 and via email at [email protected]. Learn More on Jeffrey D. Lorenzen's contact information.
Has Jeffrey D. Lorenzen been buying or selling shares of American Equity Investment Life?: Jeffrey D. Lorenzen has not been actively trading shares of American Equity Investment Life during the last ninety days. Most recently, Jeffrey D. Lorenzen sold 97,395 shares of the business's stock in a transaction on Thursday, September 21st. The shares were sold at an average price of $53.85, for a transaction totalling $5,244,720.75. Following the completion of the sale, the vice president now directly owns 30,900 shares of the company's stock, valued at $1,663,965. Learn More on Jeffrey D. Lorenzen's trading history.
Who are American Equity Investment Life's active insiders?: American Equity Investment Life's insider roster includes Axel André (CFO), Anant Bhalla (CEO), Joyce Chapman (Director), Ronald Grensteiner (EVP), James Hamalainen (EVP), Robert Howe (Director), Ted Johnson (CFO), Jeffrey Lorenzen (EVP), John Matovina (Director), Alan Matula (Director), David Mulcahy (Director), and Gerard Neugent (Director). Learn More on American Equity Investment Life's active insiders.
Are insiders buying or selling shares of American Equity Investment Life?: In the last twelve months, American Equity Investment Life insiders bought shares 4 times. They purchased a total of 1,062 shares worth more than $42,341.99. In the last twelve months, insiders at the financial services provider sold shares 9 times. They sold a total of 563,299 shares worth more than $30,415,632.40. The most recent insider tranaction occured on September, 21st when CFO Axel Andre sold 29,273 shares worth more than $1,576,936.51. Insiders at American Equity Investment Life own 1.8% of the company. Learn More about insider trades at American Equity Investment Life.
Information on this page was last updated on 9/21/2023.

Jeffrey D. Lorenzen Insider Trading History at American Equity Investment Life

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/21/2023	Sell	97,395	$53.85	$5,244,720.75	30,900
8/9/2022	Sell	25,000	$40.00	$1,000,000.00	36,439
1/7/2022	Sell	20,000	$41.10	$822,000.00
6/28/2019	Sell	12,413	$27.25	$338,254.25	41,030
2/18/2016	Buy	1,824	$13.70	$24,988.80	19,505
1/6/2016	Buy	2,680	$21.95	$58,826.00	17,681

Jeffrey D. Lorenzen Buying and Selling Activity at American Equity Investment Life

American Equity Investment Life Company Overview

American Equity Investment Life Holding Company, through its subsidiaries, provides life insurance products in the United States. The company issues fixed index and rate annuities, as well as single premium immediate annuities. It markets its products through independent agents, including independent marketing organizations, broker/dealers, banks, and registered investment advisors. The company was incorporated in 1995 and is based in West Des Moines, Iowa.

Today's Range

Now: $56.21

$55.61

$56.29

50 Day Range

MA: $55.75

$55.11

$56.32

2 Week Range

Now: $56.21

$36.69

$56.40

Volume

556,043 shs

Average Volume

544,121 shs

Market Capitalization

$4.46 billion

P/E Ratio

26.27

Dividend Yield

0.68%

Beta

0.8

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Jeffrey Lorenzen Biography and Net Worth

What is Jeffrey D. Lorenzen's net worth?

How old is Jeffrey D. Lorenzen?

What is Jeffrey D. Lorenzen's salary?

How do I contact Jeffrey D. Lorenzen?

Has Jeffrey D. Lorenzen been buying or selling shares of American Equity Investment Life?

Who are American Equity Investment Life's active insiders?

Are insiders buying or selling shares of American Equity Investment Life?